Leukemia Clinical Trials

Showing 1121-1140 of 5,235 trials

Asthma Inflammation Research

NCT01536522

The overall goal of the Asthma Inflammation Research \[AIR\] Translational Program is to create an integrated multidisciplinary team for the focused purpose of development of diagnostic and prognostic tests informative for airway inflammation, and for the design of innovative, targeted biologic therapeutics. The overarching aims of the AIR program are to conceptualize, develop, and test the next-generation therapeutics, and novel asthma diagnostic and prognostic tools that will allow us to improve the standard of asthma care.

AsthmaAllergic AsthmaNon-allergic Asthma

The Cleveland Clinic60 participantsStarted Jan 2011

Cleveland, Ohio, United States

RECRUITINGPhase 2

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT03314974

This is a Phase II study of allogeneic hematopoietic stem cell transplant (HCT) using a myeloablative preparative regimen (of either total body irradiation (TBI); or, fludarabine/busulfan for patients unable to receive further radiation). followed by a post-transplant graft-versus-host disease (GVHD) prophylaxis regimen of post-transplant cyclophosphamide (PTCy), tacrolimus (Tac), and mycophenolate mofetil (MMF).

Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more

Masonic Cancer Center, University of Minnesota300 participantsStarted Mar 2018

Minneapolis, Minnesota, United States

Asthma Inflammation Research

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Related Searches

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping

A Study of E7820 in People With Bone Marrow (Myeloid) Cancers

A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor

A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment

A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer

Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy

A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma

Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer

The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy

Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

Early Versus Interval Laparoscopic Cholecystectomy for Acute Cholecystitis

The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies